Provention Bio
PRVB
#4383
Rank
S$3.05 B
Marketcap
S$32.11
Share price
0.00%
Change (1 day)
490.88%
Change (1 year)

Revenue for Provention Bio (PRVB)

Revenue in 2022 (TTM): S$17.4 Million

According to Provention Bio's latest financial reports the company's current revenue (TTM ) is S$16.57 Million. In 2021 the company made a revenue of S$1.88 Million an increase over the revenue in the year 2020 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Provention Bio from 2017 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) S$17.4 M822.82%
2021 S$1.88 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
S$0.82 B 4,880.76% Jersey
Novavax
NVAX
S$1.31 B 7,843.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
S$0.18 M-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
S$28.07 M 69.36%๐Ÿ‡ฌ๐Ÿ‡ง UK